Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qilian International Holding Group Limited (QLI)
NASDAQ:QLI
RESEARCH TOOLSreports
Qilian International Holding Group Limited (QLI) Stock Price & Analysis
38 Followers
QLI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.36 - $1.33
Previous Close$0.7
Volume64.47K
Average Volume (3M)168.38K
Market Cap
$25.02M
Enterprise Value$13.73M
Total Cash (Recent Filing)$14.98M
Total Debt (Recent Filing)$1.77M
Price to Earnings (P/E)-3.2
Beta-0.21
Next Earnings
Sep 12, 2024EPS EstimateN/A
Last Dividend Ex-Date
Feb 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding35,750,000
10 Day Avg. Volume400,937
30 Day Avg. Volume168,385
Standard Deviation0.31
R-Squared0.06
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.49
Price to Sales (P/S)0.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.20
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Qilian International Holding Group Limited News
PremiumCompany Announcements
Qilian International Approves Major Share Restructuring
QLI FAQ
What was Qilian International Holding Group Limited’s price range in the past 12 months?
Qilian International Holding Group Limited lowest stock price was $0.35 and its highest was $1.33 in the past 12 months.
What is Qilian International Holding Group Limited’s market cap?
Currently, no data Available
When is Qilian International Holding Group Limited’s upcoming earnings report date?
Qilian International Holding Group Limited’s upcoming earnings report date is Sep 12, 2024 which is in 139 days.
How were Qilian International Holding Group Limited’s earnings last quarter?
Qilian International Holding Group Limited released its earnings results on Feb 09, 2024. The company reported -$0.232 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.232.
Is Qilian International Holding Group Limited overvalued?
According to Wall Street analysts Qilian International Holding Group Limited’s price is currently Overvalued.
Does Qilian International Holding Group Limited pay dividends?
Qilian International Holding Group Limited pays a Notavailable dividend of $0.05 which represents an annual dividend yield of N/A. See more information on Qilian International Holding Group Limited dividends here
What is Qilian International Holding Group Limited’s EPS estimate?
Qilian International Holding Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qilian International Holding Group Limited have?
Qilian International Holding Group Limited has 35,750,000 shares outstanding.
What happened to Qilian International Holding Group Limited’s price movement after its last earnings report?
Qilian International Holding Group Limited reported an EPS of -$0.232 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.769%.
Which hedge fund is a major shareholder of Qilian International Holding Group Limited?
Currently, no hedge funds are holding shares in QLI
---
Qilian International Holding Group Limited Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-41.66%
12-Months-Change
Fundamentals
Return on Equity
-16.24%
Trailing 12-Months
Asset Growth
-20.56%
Trailing 12-Months
Company Description
Qilian International Holding Group Limited
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licoriceproducts and TCMD; Fertilizer; and Heparinproducts and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generate most of the revenue.
---
Technical Analysis
---